1567334-76-2Relevant articles and documents
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Cav 2.2) blockers for the treatment of pain
Wall, Mark J.,Subasinghe, Nalin L.,Winters, Michael P.,Lubin, Mary Lou,Finley, Michael F.A.,Qin, Ning,Brandt, Michael R.,Neeper, Michael P.,Schneider, Craig R.,Colburn, Raymond W.,Flores, Christopher M.,Sui, Zhihua
, p. 3780 - 3783 (2018)
A novel series of pyrazolyltetrahydropyran N-type calcium channel blockers are described. Structural modifications of the series led to potent compounds in both a cell-based fluorescent calcium influx assay and a patch clamp electrophysiology assay. Representative compounds from the series were bioavailable and showed efficacy in the rat CFA and CCI models of inflammatory and neuropathic pain.
SUBSTITUTED PYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS
-
Page/Page column 114; 115; 116, (2014/03/22)
The present invention relates to compounds of Formula (I), wherein X1, X2, X3, X4, R1, R2, R3, and Q are as defined herein, useful as N-type calcium channel blockers.